<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26203" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Ophthalmia Neonatorum</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Castro Ochoa </surname>
            <given-names>Kenny J.</given-names>
          </name>
          <aff>Lincoln Medical and Mental Health Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mendez</surname>
            <given-names>Magda D.</given-names>
          </name>
          <aff>Lincoln Medical Center/Weil Cornell</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kenny Castro Ochoa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Magda Mendez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26203.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Ophthalmia neonatorum is a type of conjunctivitis that takes place in the neonatal period. This condition is commonly transmitted during vaginal delivery and has associations with severe complications, including corneal perforation, potentially resulting in blindness. This activity outlines the role of pediatricians and neonatologists in evaluating, managing, and improving the outcome of patients with this eye disease.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of ophthalmia neonatorum.</p></list-item><list-item><p>Review the evaluation of children with ophthalmia neonatorum.</p></list-item><list-item><p>Summarize the treatment and management options available for ophthalmia neonatorum.</p></list-item><list-item><p>Outline the importance of the interprofessional team's role in delivering care to improve outcomes for patients affected by ophthalmia neonatorum.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26203&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26203">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26203.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Ophthalmia neonatorum is a type of conjunctivitis&#x000a0;seen in the neonatal period, occurring in 1% to 12% of neonates (see <bold>Image.</bold> Ophthalmia Neonatorum). This condition commonly gets transmitted during vaginal delivery, and it correlates with severe complications such as corneal ulceration and perforation, which can potentially result in permanent blindness. Due to the significant morbidity of this disease, new guidelines were issued by the U.S. Preventive Service Task Force regarding antibiotic use in all newborns to prevent ophthalmia neonatorum. These guidelines were put in place to reduce vertical transmission of gonococcal infection, which can occur in up to 50% of the cases when prophylaxis is not given.</p>
        <p>In 2010, The Centers for Disease Control and Prevention (CDC) developed the guidelines for the management of sexually transmitted infections, in which prophylaxis with erythromycin ointment (0.5%) or azithromycin solution 1% (if erythromycin not available) is recommended as a part of the routine newborn care for ophthalmia neonatorum prevention, considering that is effective and inexpensive. In these guidelines, routine screening and appropriate treatment, including the partners of all pregnant women during the first trimester is also a recommendation.&#x000a0;During the third trimester, screening follow-up for those women considered high risk (multiple sex partners, 24 years of age or younger, etc.) is advisable.&#x000a0;Silver nitrate effectively prevents gonococcal ophthalmia neonatorum; however, its use has been discontinued due to the high risk of developing chemical conjunctivitis in approximately 50% of the cases.<xref ref-type="bibr" rid="article-26203.r1">[1]</xref><xref ref-type="bibr" rid="article-26203.r2">[2]</xref></p>
      </sec>
      <sec id="article-26203.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Research has identified various microorganisms as the causing agents of this eye disease, such as&#x000a0;<italic toggle="yes">Chlamydia trachomatis</italic>, <italic toggle="yes">Neisseria gonorrhoeae</italic>, viral infections, and bacteria from the gastrointestinal tract and the skin.</p>
        <p>Etiology of ophthalmia neonatorum classifies as either sexually transmitted bacteria, non-sexually transmitted bacteria, viral, and chemical. <italic toggle="yes">Neisseria gonorrhea</italic> accounts for&#x000a0;less than 1% of ophthalmia cases worldwide; however, in babies born to mothers infected with <italic toggle="yes">N. gonorrhoeae,&#x000a0;</italic>up to 48% develop ophthalmia neonatorum; in rare cases, if untreated or inadequately treated, meningitis and septicemia may develop. Non-sexually transmitted bacteria, like <italic toggle="yes">Staphylococcus aureus</italic>, Streptococcal species, gram-negative bacteria, and<italic toggle="yes"> Haemophilus</italic>, account for 30&#x000a0;to 50% of ophthalmia cases.&#x000a0;Adenovirus and herpes simplex virus are the most common causes of viral conjunctivitis.<xref ref-type="bibr" rid="article-26203.r3">[3]</xref><xref ref-type="bibr" rid="article-26203.r4">[4]</xref><xref ref-type="bibr" rid="article-26203.r5">[5]</xref></p>
      </sec>
      <sec id="article-26203.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Before 1880, ophthalmia neonatorum was the leading cause of permanent blindness in neonates, mainly caused by <italic toggle="yes">Neisseria gonorrhoeae</italic>. In 1881 Dr. Crede used 2% of silver nitrate for the first time at the time of birth for ophthalmia prophylaxis. After that time, the epidemiology of this eye disease changed, and the incidence of N. gonorrhoeae as the causal agent of ophthalmia decreased from 10% to 0.3%.<xref ref-type="bibr" rid="article-26203.r4">[4]</xref>&#x000a0;</p>
        <p>In the United States, ophthalmia neonatorum caused by <italic toggle="yes">N. gonorrhoeae</italic> has an incidence of 0.3&#x000a0;per 1000 live births, while <italic toggle="yes">Chlamydia trachomatis</italic> represents 8.2&#x000a0;of 1000 cases.&#x000a0;</p>
      </sec>
      <sec id="article-26203.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A complete history and physical exam, including the chronologic appearance of presenting signs of conjunctivitis, are crucial but not specific for the diagnosis. It is known that the timing and characteristics of the clinical presentation may be typical depending on the etiologic agent; however, some of the clinical manifestations such as chemosis, erythema, and discharge can be present regardless of the cause.&#x000a0;</p>
        <p><italic toggle="yes">Chlamydia trachomatis</italic> and <italic toggle="yes">Neisseria gonorrhoeae</italic> are transmitted at the time of the delivery. When these microorganisms are the suspected cause of neonatal conjunctivitis, the clinician should obtain information about maternal infections during the prenatal period should be obtained. It is also of the utmost importance to perform adequate screening for other sexually transmitted organisms, including the human immunodeficiency virus (HIV).&#x000a0; &#x000a0;</p>
        <p>The timing of the onset of symptoms can also serve as an appropriate guide in managing these patients. Chemical conjunctivitis should be suspected in patients that present with erythema, chemosis, eyelid edema, and discharge within the first 24 hours after birth. Gonococcal conjunctivitis usually presents between 2&#x000a0;to 5 days; the hallmark is a thick and purulent eye discharge accompanied by remarkable chemosis and eyelids edema. On the other hand, ophthalmia neonatorum due to <italic toggle="yes">Chlamydia trachomatis</italic> is seen 5&#x000a0;to 14 days after birth, both eyes may be affected, but unilateral involvement can occur in some cases. The eye discharge is initially copious, then becomes purulent, and it is associated with eyelid swelling.</p>
        <p>Herpes simplex conjunctivitis is uncommon, accounting for less than 1% of ophthalmia cases; however, it merits suspicion in patients&#x000a0;presenting with unilateral chemosis, serosanguineous discharge that rarely becomes purulent, coupled to vesicular lesions surrounding the eyelids or oral ulcers and lymphadenopathy. Its identification is crucial to prevent complications, including disseminated disease and meningoencephalitis, that may be lethal if left untreated.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-26203.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>When ophthalmia neonatorum is suspected, confirmation of the etiology is warranted. A sample from the eye discharge should be taken and sent for Gram stain and culture in Thayer-Martin media and chocolate agar, especially if <italic toggle="yes">N. gonorrhoeae</italic> is the possible causal agent; this guarantees that proper treatment is given and thus, ensures the prevention of potential complications which, is essential for a good prognosis and outcome. In <italic toggle="yes">Chlamydia trachomatis</italic> infection, polymerase chain reaction (PCR), direct fluorescent antibody staining, and Giemsa-stained epithelial cells from conjunctival scraping can help make the diagnosis. Some authors have recommended nucleic acid amplification tests (NAATs) from conjunctival swabs&#x000a0;when chlamydial ophthalmia is suspected; however, these tests have not Food and Drug Administration approval for the detection of chlamydia in the conjunctiva. For herpetic conjunctivitis, the standard diagnostic test for the isolation of the virus is virus culture and viral DNA detection by PCR.&#x000a0;&#x000a0;</p>
        <p>Patients with signs of systemic infection that look unwell&#x000a0;may have spread disease manifesting as meningitis, bacteremia, arthritis, or sepsis; in&#x000a0;those cases, additional&#x000a0;investigation including blood culture, cerebrospinal fluid for gram stain are warranted.<xref ref-type="bibr" rid="article-26203.r6">[6]</xref></p>
      </sec>
      <sec id="article-26203.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Patients&#x000a0;with suspected neonatal conjunctivitis&#x000a0;should be managed based on initial clinical assessment and evaluation of possible complications. If&#x000a0;the clinician has high suspicious of neonatal conjunctivitis&#x000a0;and the confirmatory tests of the infection are not available, treatment against both (<italic toggle="yes">Chlamydia trachomatis</italic> and <italic toggle="yes">Neisseria gonorrhoeae</italic>) should start to avoid complications.&#x000a0;</p>
        <p>If the clinician has established the diagnosis of gonococcal ophthalmia neonatorum, immediate initiation of treatment, including hospitalization, is crucial. The first-line treatment of choice is a single dose of ceftriaxone 25&#x000a0;to 50 mg/kg/24 hr, with a maximum of 125 mg. Frequent eye irrigation with sterile isotonic saline is also recommended as an adjunct therapy. An alternative regimen is cefotaxime 100 mg/kg in a single dose.&#x000a0;If chlamydial conjunctivitis is confirmed, oral erythromycin 50 mg/kg/24 hr for two weeks remains the regimen of choice; topical erythromycin can be used as adjunct therapy as well. Conjunctivitis secondary to staphylococcal species and pseudomonas requires treatment with systemic antibiotics. On the other hand, patients with herpes simplex conjunctivitis should have treatment with systemic antiviral therapy, along with topical ophthalmic drugs, including 0.15% ganciclovir or 1% trifluridine for 14 days. An ophthalmology consult is necessary in these cases.&#x000a0;<xref ref-type="bibr" rid="article-26203.r7">[7]</xref><xref ref-type="bibr" rid="article-26203.r8">[8]</xref><xref ref-type="bibr" rid="article-26203.r9">[9]</xref></p>
        <p>Recommendations about management in asymptomatic babies born to mothers infected with <italic toggle="yes">Chlamydia trachomatis</italic> infection exist; these babies require close monitoring for the appearance of clinical symptoms suggestive of chlamydia ocular or respiratory infections. Oral erythromycin is not recommended in&#x000a0;asymptomatic babies&#x000a0;due to an increased risk of developing pyloric stenosis.<xref ref-type="bibr" rid="article-26203.r10">[10]</xref></p>
      </sec>
      <sec id="article-26203.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The list of differential diagnosis includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Dacryocystitis</p>
          </list-item>
          <list-item>
            <p>Congenital glaucoma</p>
          </list-item>
          <list-item>
            <p>Keratitis</p>
          </list-item>
          <list-item>
            <p>Nasolacrimal duct obstruction</p>
          </list-item>
          <list-item>
            <p>Cellulitis&#x000a0;</p>
          </list-item>
        </list>
        <p>&#x000a0;Several of these conditions may present with similar signs and symptoms; since this is the case, it is necessary to perform a complete history that includes maternal and family histories. As with any other condition, the addition of a detailed physical exam may also help with the diagnosis. If the diagnosis remains uncertain after evaluation, an ophthalmology referral may be warranted.&#x000a0;</p>
      </sec>
      <sec id="article-26203.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Before 1880, ophthalmia neonatorum due to Neisseria gonorrhoeae was the most common cause of neonatal blindness. Early detection and timely treatment of infected mothers are essential elements to prevent permanent ocular damage. If left untreated or partially treated, corneal ulceration, perforation, and blindness can occur. Approximately 10000 cases of blindness per year are secondary to ophthalmia neonatorum worldwide. Fortunately, in most cases, neonatal ophthalmia neonatorum caused by non-gonococcal bacteria is a mild disease and has a good prognosis; however, up to 50% of babies born to mothers with chlamydia infection may develop neonatal conjunctivitis, and from those, between 10%&#x000a0;to 20% are at risk to having pneumonia.&#x000a0;Chemical conjunctivitis secondary to silver nitrate is self-limiting.<xref ref-type="bibr" rid="article-26203.r7">[7]</xref><xref ref-type="bibr" rid="article-26203.r11">[11]</xref><xref ref-type="bibr" rid="article-26203.r12">[12]</xref></p>
      </sec>
      <sec id="article-26203.s10" sec-type="Complications">
        <title>Complications</title>
        <p>If left untreated, babies are at high risk of developing corneal ulceration, ocular globe perforation, and permanent blindness. In rare cases, there have been reports of the spread of disease, and meningitis, sepsis, and even death may result.&#x000a0;</p>
      </sec>
      <sec id="article-26203.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Mothers should be educated and counseled about how important, regular prenatal visits are. It is imperative to screen for <italic toggle="yes">Neisseria gonorrhoeae</italic> and <italic toggle="yes">Chlamydia trachomatis</italic> infections along with all other essential tests done during these visits.</p>
      </sec>
      <sec id="article-26203.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Ophthalmia neonatorum is a type of conjunctivitis&#x000a0;encountered in the neonatal period (the first 28 days after birth).</p>
          </list-item>
          <list-item>
            <p>In the United States, <italic toggle="yes">N. gonorrhoeae</italic> conjunctivitis has an incidence of 0.3 per 1000 live births, while Chlamydia trachomatis represents 8.2 per 1000 cases.</p>
          </list-item>
          <list-item>
            <p>Approximately 10000 cases of blindness per year are secondary to ophthalmia neonatorum worldwide.</p>
          </list-item>
          <list-item>
            <p>Prophylaxis with erythromycin ointment (0.5%) is part of routine newborn care and is currently the only drug approved for ophthalmia neonatorum prevention.</p>
          </list-item>
          <list-item>
            <p>Early detection and initiation of treatment are crucial elements for a good outcome.</p>
          </list-item>
          <list-item>
            <p>All pregnant women should have screening for sexually transmitted infections and adequately treated.</p>
          </list-item>
          <list-item>
            <p>A multidisciplinary approach is critical for the successful management of patients with ophthalmia neonatorum.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26203.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Ophthalmia neonatorum is an acute eye inflammatory process that occurs in the neonatal period (first four weeks of life). When this condition is suspected, prompt isolation of the etiologic agent is warranted. If left untreated, gonococcal neonatal conjunctivitis can lead to severe complications, including corneal ulceration and perforation, resulting in permanent blindness. Early detection and initiation of treatment are crucial elements for a good outcome.</p>
        <p>By following the above guidelines and steps, the clinician will decide if the diagnosis exists or is a possibility and initiate appropriate antimicrobial therapy. It is prudent to include an infectious disease specialist and/or a pharmacist with infectious disease board certification for an additional consult. Neonatal specialized nursing staff will be tasked with medication administration and monitoring the progress of therapy for the infant, charting all observations, and reporting any concerns to the rest of the team.</p>
        <p>An interprofessional team constituted by pediatricians, neonatologists, ophthalmologists, nurses, pharmacists, and infectious disease specialists, provides an integrated approach to neonatal conjunctivitis that, along with communication and shared decision making, can help achieve the best possible outcomes.&#x000a0;[Level 5]</p>
      </sec>
      <sec id="article-26203.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26203&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26203">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/ophthalmia-neonatorum/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26203">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26203/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26203">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26203.s15">
        <fig id="article-26203.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Ophthalmia Neonatorum Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ophthalmia__neonatorum" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26203.s16">
        <title>References</title>
        <ref id="article-26203.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Curry</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Doubeni</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Epling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kemper</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Kubik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Landefeld</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2019</year>
            <month>Jan</month>
            <day>29</day>
            <volume>321</volume>
            <issue>4</issue>
            <fpage>394</fpage>
            <page-range>394-398</page-range>
            <pub-id pub-id-type="pmid">30694327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mallika</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Asok</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Faisal</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Intan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Neonatal conjunctivitis - a review.</article-title>
            <source>Malays Fam Physician</source>
            <year>2008</year>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-81</page-range>
            <pub-id pub-id-type="pmid">25606121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>MacDonald</surname>
                <given-names>NE</given-names>
              </name>
              <collab>Canadian Paediatric Society, Infectious Diseases and Immunization Committee</collab>
            </person-group>
            <article-title>Preventing ophthalmia neonatorum.</article-title>
            <source>Paediatr Child Health</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-6</page-range>
            <pub-id pub-id-type="pmid">25838784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matejcek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Treatment and prevention of ophthalmia neonatorum.</article-title>
            <source>Can Fam Physician</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>59</volume>
            <issue>11</issue>
            <fpage>1187</fpage>
            <page-range>1187-90</page-range>
            <pub-id pub-id-type="pmid">24235191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thanathanee</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Conjunctivitis: systematic approach to diagnosis and therapy.</article-title>
            <source>Curr Infect Dis Rep</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-8</page-range>
            <pub-id pub-id-type="pmid">21365377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Berman</surname>
                <given-names>S</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention (CDC)</collab>
            </person-group>
            <article-title>Sexually transmitted diseases treatment guidelines, 2010.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2010</year>
            <month>Dec</month>
            <day>17</day>
            <volume>59</volume>
            <issue>RR-12</issue>
            <fpage>1</fpage>
            <page-range>1-110</page-range>
            <pub-id pub-id-type="pmid">21160459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hammerschlag</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Chlamydial and gonococcal infections in infants and children.</article-title>
            <source>Clin Infect Dis</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>53 Suppl 3</volume>
            <fpage>S99</fpage>
            <page-range>S99-102</page-range>
            <pub-id pub-id-type="pmid">22080275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zloto</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gharaibeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mezer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stankovic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Isenberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wygnanski-Jaffe</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmia neonatorum treatment and prophylaxis: IPOSC global study.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>254</volume>
            <issue>3</issue>
            <fpage>577</fpage>
            <page-range>577-82</page-range>
            <pub-id pub-id-type="pmid">26810921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zuppa</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>D'Andrea</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Catenazzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Scorrano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Romagnoli</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmia neonatorum: what kind of prophylaxis?</article-title>
            <source>J Matern Fetal Neonatal Med</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>769</fpage>
            <page-range>769-73</page-range>
            <pub-id pub-id-type="pmid">21534852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eberly</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Eide</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Nylund</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Azithromycin in early infancy and pyloric stenosis.</article-title>
            <source>Pediatrics</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>135</volume>
            <issue>3</issue>
            <fpage>483</fpage>
            <page-range>483-8</page-range>
            <pub-id pub-id-type="pmid">25687145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>MacDonald</surname>
                <given-names>NE</given-names>
              </name>
              <collab>Canadian Paediatric Society, Infectious Diseases and Immunization Committee</collab>
            </person-group>
            <article-title>Preventing ophthalmia neonatorum.</article-title>
            <source>Can J Infect Dis Med Microbiol</source>
            <year>2015</year>
            <season>May-Jun</season>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>122</fpage>
            <page-range>122-5</page-range>
            <pub-id pub-id-type="pmid">26236350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26203.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darville</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Chlamydia trachomatis infections in neonates and young children.</article-title>
            <source>Semin Pediatr Infect Dis</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>235</fpage>
            <page-range>235-44</page-range>
            <pub-id pub-id-type="pmid">16210104</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
